Advertisement
APO vs TEVA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APO is a StrongBuy and TEVA is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APO’s FA Score shows that 1 FA rating(s) are green whileTEVA’s FA Score has 0 green FA rating(s).
- APO’s FA Score: 1 green, 4 red.
- TEVA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APO’s TA Score shows that 6 TA indicator(s) are bullish while TEVA’s TA Score has 3 bullish TA indicator(s).
- APO’s TA Score: 6 bullish, 4 bearish.
- TEVA’s TA Score: 3 bullish, 5 bearish.
Price Growth
APO (@Investment Managers) experienced а +0.49% price change this week, while TEVA (@Pharmaceuticals: Other) price change was -3.55% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was +2.05%. For the same industry, the average monthly price growth was +10.60%, and the average quarterly price growth was +14.57%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +62.47%. For the same industry, the average monthly price growth was +4.88%, and the average quarterly price growth was +67.74%.
Reported Earning Dates
APO is expected to report earnings on Oct 29, 2025.
TEVA is expected to report earnings on Nov 06, 2025.
Industries' Descriptions
@Investment Managers (+2.05% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
@Pharmaceuticals: Other (+62.47% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| APO | TEVA | APO / TEVA | |
| Capitalization | 63.9B | 15.1B | 423% |
| EBITDA | 6.65B | 1.56B | 427% |
| Gain YTD | -11.205 | -27.223 | 41% |
| P/E Ratio | 13.58 | 22.62 | 60% |
| Revenue | 32.6B | 15.8B | 206% |
| Total Cash | 170B | 3.23B | 5,270% |
| Total Debt | 8.09B | 20.2B | 40% |
APO | TEVA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 29 | 68 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 47 | 60 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
APO's Valuation (50) in the Investment Managers industry is in the same range as TEVA (50) in the Pharmaceuticals Generic industry. This means that APO’s stock grew similarly to TEVA’s over the last 12 months.
APO's Profit vs Risk Rating (29) in the Investment Managers industry is somewhat better than the same rating for TEVA (68) in the Pharmaceuticals Generic industry. This means that APO’s stock grew somewhat faster than TEVA’s over the last 12 months.
APO's SMR Rating (100) in the Investment Managers industry is in the same range as TEVA (100) in the Pharmaceuticals Generic industry. This means that APO’s stock grew similarly to TEVA’s over the last 12 months.
APO's Price Growth Rating (47) in the Investment Managers industry is in the same range as TEVA (60) in the Pharmaceuticals Generic industry. This means that APO’s stock grew similarly to TEVA’s over the last 12 months.
APO's P/E Growth Rating (100) in the Investment Managers industry is in the same range as TEVA (100) in the Pharmaceuticals Generic industry. This means that APO’s stock grew similarly to TEVA’s over the last 12 months.
| APO | TEVA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 45% | N/A |
| Stochastic ODDS (%) | 1 day ago 60% | 1 day ago 75% |
| Momentum ODDS (%) | 6 days ago 70% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 76% | N/A |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 70% | 1 day ago 67% |
| Advances ODDS (%) | 6 days ago 71% | 22 days ago 72% |
| Declines ODDS (%) | 15 days ago 64% | 5 days ago 73% |
| BollingerBands ODDS (%) | 1 day ago 58% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 67% | 1 day ago 61% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ECNS | 33.66 | 0.35 | +1.06% |
| iShares MSCI China Small-Cap ETF | |||
| JPI | 20.54 | 0.05 | +0.22% |
| Nuveen Preferred Securities & Income Opportunities Fund | |||
| USXF | 54.51 | 0.04 | +0.07% |
| iShares® ESG Advanced MSCI USA ETF | |||
| SEPU | 26.85 | -0.12 | -0.46% |
| AllianzIM U.S. Equity Buffer15 UncSepETF | |||
| HAUS | 18.05 | -0.25 | -1.38% |
| Residential REIT ETF | |||
APO and
Correlation & Price change
A.I.dvisor indicates that over the last year, APO has been closely correlated with KKR. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if APO jumps, then KKR could also see price increases.